| Emily Cheng, | |
|
40 N Park Victoria Dr Ste B, Milpitas, CA 95035-4600 | |
| (408) 586-9663 | |
| Not Available |
| Full Name | Emily Cheng |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 40 N Park Victoria Dr Ste B, Milpitas, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033975743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 109887 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Cheng, 10141 Pasadena Ave Apt A, Cupertino, CA 95014-5969 Ph: (559) 936-5383 | Emily Cheng, 40 N Park Victoria Dr Ste B, Milpitas, CA 95035-4600 Ph: (408) 586-9663 |
News Archive
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL147 (SAR245408), a selective, orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K). Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Benrikal Services to distribute the Bengal Radial Compression Band in the United States.
An international team of scientists has identified an association between heritable, rare mutations in the RINT1 gene and increased risk of early onset breast cancer, according to research reported today (Oct. 24) at the American Society of Human Genetics 2013 annual meeting in Boston.
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
› Verified 7 days ago
Dr. Timothy Thoai Nguyen, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 991 Montague Expy Ste 102, Milpitas, CA 95035 Phone: 408-946-6666 Fax: 408-935-8805 | |
Dr. Milagros Lingat Taberna, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 282 S Main St, Milpitas, CA 95035 Phone: 408-946-4815 Fax: 408-946-3249 | |
Roddy Miller, DDS Dentist Medicare: Medicare Enrolled Practice Location: 142 Ranch Dr, Milpitas, CA 95035 Phone: 408-262-4434 Fax: 408-945-7631 | |
Dr. Suruchi Laxman Warwatkar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 470 E Calaveras Blvd, Milpitas, CA 95035 Phone: 408-636-2937 | |
Dr. Manjula Jaishankar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1295 S Park Victoria Dr, Milpitas, CA 95035 Phone: 408-945-0411 | |
Stanley P Chin, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 450 E Calaveras Blvd, Milpitas, CA 95035 Phone: 408-263-5252 Fax: 408-263-8579 |